SCR-LIP-000390 · Claim · machine-readable JSON →
In a retrospective study of lipedema patients undergoing multistage lymph-sparing liposuction, BMI decreased by a median of 2.7 kg/m2 and patients with BMI ≤35 had greater symptom (VAS composite 51.6% vs 25.3%) and conservative-therapy-need reduction than those with BMI >35, but liposuction volume did not correlate with symptom or treatment-need reduction; the study did not evaluate bariatric surgery or substantial weight loss as the intervention.
Created: 2026-05-31 · Last updated: 2026-05-31
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- DOI:10.1111/dth.14534 — refines · case series · 2022
The article studies liposuction, not bariatric surgery or weight loss as the intervention; it indirectly bears on the question by showing lower BMI (≤35) predicts better outcomes and a small BMI decrease post-op, but does not directly test
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000024